Cytiva will open a new 7,400m² manufacturing facility in Grens, Switzerland on May 31. The site will manufacture single use kits for the Sepax and Sefia cell processing systems, as well as consumables for Xuri cell expansion systems. It will also serve as a “Center of Excellence” for Cytiva’s cell and gene therapy business and will be a base for European customer training programs. The site will be home to 250 associates.

“Cell and gene therapies have the potential to change the global healthcare landscape,” says Catarina Flyborg, vice president, cell, and gene therapy. “Our new facility in Grens will enable us to meet global demand for our products, while working with our customers to meet their immediate training and development needs. This facility brings us another step closer to our vision where access to life-changing therapies transforms human health.”

The existing site in Eysins will continue operations through 2023, while full production transfers to the new site in Grens.

The facility will quadruple Cytiva’s capacity for manufacturing Sefia, Sepax, and Xuri consumable products with two new ISO class 7 cleanrooms. The design of the facility adopts GMP principles from raw materials entering the building, through the manufacturing process, to the shipment of finished products.

The new site has been built to Swiss Minergie standards, a sustainable building standard recognized globally for its effectiveness in achieving lower energy and resource consumption, according to a company official, who adds that building to this standard provides high-grade, air-tight building envelopes and the continuous renewal of air in the building using an energy-efficient ventilation system.

The building is powered by 100% renewable electricity and has roof mounted solar panels. It also has five distinct HVAC systems that optimize environmental conditions in each functional area. Cytiva is investigating the use of ‘dynamic’ cleanroom controls which could further reduce power usage by up to 60%.

An R&D facility is located on the first floor, which consists of several laboratories designed for multidisciplinary engineering and cell biology processing capabilities. Cytiva notes that the customer training center, located on the second floor, is a fully equipped 100m² BSL2 laboratory that will enable process and application training with Cytiva instruments, consumables, and software. Cytiva associates will also be able to use this facility to develop knowledge and skills on current and future products and processes.

Recruitment is ongoing in Grens to hire manufacturing staff, management, as well as warehouse operators, material handlers, and R&D scientists. Go here to see all the available roles.

Previous articleAvantor Collaborates with Cytovance Biologics
Next articlePotential Drug Discovery May Halt Meningioma Recurrence